← All Inogen INC filings

Inogen INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
INGN
Inogen INC
SCHEDULE: Vanguard Group Amends Inogen Stake to Zero
The Vanguard Group has filed an amended Schedule 13G for Inogen Inc., reporting 0% beneficial ownership following an internal realignment.
NASDAQ
INGN
Inogen INC
SCHEDULE 13G/A: BlackRock Discloses 6.2% Passive Stake in Inogen Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% beneficial ownership stake in Inogen Inc.'s common stock as of June 30, 2025.
NASDAQ
INGN
Inogen INC
SCHEDULE 13G/A: Camber Capital Management and Stephen DuBois Disclose 3.7% Passive Stake in Inogen Inc.
Camber Capital Management LP and Stephen DuBois have filed an amended Schedule 13G, reporting a passive beneficial ownership of 3.7% of Inogen Inc.'s common stock, totaling 975,000 shares.
NASDAQ
INGN
Inogen INC
SCHEDULE 13G/A: Brown Capital Management Reports Zero Beneficial Ownership in Inogen, Inc.
Brown Capital Management, LLC has filed an amended Schedule 13G indicating it no longer holds beneficial ownership in Inogen, Inc., reporting 0% of the common stock.
NASDAQ
INGN
Inogen INC
SCHEDULE 13G: Chinese Medical Equipment Giant Discloses 9.9% Stake in Inogen Inc.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. and its subsidiary Yuwell (Hong Kong) Holdings Limited have disclosed a 9.9% beneficial ownership stake in U.S. medical technology company Inogen Inc.